{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:36:15Z","timestamp":1790843775740,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ijantimicag.2010.11.014","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T09:41:09Z","timestamp":1291455669000},"page":"S50-S54","source":"Crossref","is-referenced-by-count":132,"special_numbering":"S2","title":["Multidrug-resistant Gram-negative bacteria: how to treat and for how long"],"prefix":"10.1016","volume":"36","author":[{"given":"Helen","family":"Giamarellou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0005","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2165\/11315690-000000000-00000","article-title":"Multidrug-resistant Gram-negative infections: what are the treatment options?","volume":"69","author":"Giamarellou","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0015","doi-asserted-by":"crossref","unstructured":"National Nosocomial Infections Surveillance (NNIS) System report data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470\u201385.","DOI":"10.1016\/j.ajic.2004.10.001"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2010.11.014_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2005.01161.x","article-title":"Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa","volume":"11","author":"Rossolini","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0025","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19045-en","article-title":"Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe","volume":"13","author":"Souli","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/506571","article-title":"Old polymyxins are back: is resistance close?","volume":"43","author":"Li","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1586\/14787210.5.5.811","article-title":"Polymyxin B: similarities to and differences from colistin (polymyxin E)","volume":"5","author":"Kwa","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1469-0691.2005.01351.x","article-title":"Global assessment of the antimicrobial activity of polymyxin against 54731 clinical isolates of Gram-negative bacilli: report from the SENTRY Antimicrobial Surveillance Program (2001-4)","volume":"12","author":"Gales","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1179\/joc.2003.15.3.235","article-title":"In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa","volume":"15","author":"Giamarellos-Bourboulis","year":"2003","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2007.07.007","article-title":"Comparative activities of colistin, rifampicin, imipenem and sulbactam\/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases","volume":"30","author":"Tripodi","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkm178","article-title":"In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates","volume":"60","author":"Tan","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0060","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.01271-08","article-title":"Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-\u03b2-lactamase-producing Klebsiella pneumoniae isolates?","volume":"53","author":"Souli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/14787210.4.4.601","article-title":"Treatment options for multidrug-resistant bacteria","volume":"4","author":"Giamarellou","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1183\/09031936.00156906","article-title":"Ventilator-associated pneumonia due to colistin susceptible-only microorganisms","volume":"30","author":"Rios","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0075","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00134-007-0675-2","article-title":"Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"33","author":"Kallel","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0080","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1128\/AAC.01015-06","article-title":"Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients","volume":"51","author":"Hachem","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s15010-009-9148-6","article-title":"Inhaled anti-infective agents: emphasis on colistin","volume":"38","author":"Michalopoulos","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0095","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1016\/j.ijid.2009.06.032","article-title":"Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin: a new case and a systematic review of the literature","volume":"14","author":"Cascio","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0100","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/AAC.01361-08","article-title":"Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria","volume":"53","author":"Plachouras","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0105","first-page":"752","article-title":"Polymyxins \u2013 a review focusing on their nephrotoxicity","volume":"56","author":"Alberto","year":"2010","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0110","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkl562","article-title":"Colistin-resistant isolates Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster","volume":"59","author":"Antoniadou","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0115","first-page":"5","article-title":"Colistin: the loss of the last frontier?","volume":"25","author":"Giamarellou","year":"2007","journal-title":"APUA Newsletter"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/528719","article-title":"Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek university hospital","volume":"46","author":"Souli","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/649865","article-title":"An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes","volume":"50","author":"Souli","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-007-0683-2","article-title":"Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa","volume":"33","author":"Mentzelopoulos","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0135","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/CCM.0B013E3181652FAE","article-title":"Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: a matched case\u2013control study","volume":"36","author":"Matthaiou","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0140","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/AAC.00322-06","article-title":"In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, Gram-negative and Gram-positive clinical isolates from Greek hospitals","volume":"50","author":"Souli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/AAC.47.1.400-404.2003","article-title":"Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates","volume":"47","author":"Milatovic","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2008.07.031","article-title":"Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST)","volume":"33","author":"Bouchillon","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2010.11.014_bib0155","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1016\/S0924-8579(08)70026-8","article-title":"In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan","volume":"32","author":"Liu","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0160","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.01114-07","article-title":"Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program","volume":"52","author":"Castanheira","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2005.05.006","article-title":"Pharmacokinetic\/pharmacodynamic profile for tigecycline\u2014a new glycylcycline antimicrobial agent","volume":"52","author":"Meagher","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2010.11.014_bib0170","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1093\/jac\/dkn242","article-title":"Tigecycline pharmacokinetic\/pharmacodynamic update","volume":"62","author":"MacGowan","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2009.02.009","article-title":"Tigecycline in the treatment of infections from multi-drug resistant Gram-negative pathogens","volume":"58","author":"Poulakou","year":"2009","journal-title":"J Infect"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2010.11.014_bib0180","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/431675","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin\u2013aztreonam","volume":"41","author":"Ellis-Grosse","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkl441","article-title":"Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report","volume":"59","author":"Peleg","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1469-0691.2009.03115.x","article-title":"Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control","volume":"16","author":"Carmeli","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0195","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/AAC.00782-08","article-title":"Prospective observational study of the impact of VIM-1 metallo-\u03b2-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections","volume":"53","author":"Daikos","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0200","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2009.10.019","article-title":"Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1469-0691.2009.02921.x","article-title":"Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation","volume":"16","author":"Michalopoulos","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0210","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/AAC.00556-09","article-title":"ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates","volume":"53","author":"Endimiani","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0215","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jac\/dkp197","article-title":"In vitro activity of the \u03b2-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases","volume":"64","author":"Stachyra","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0220","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.01535-08","article-title":"Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa","volume":"53","author":"Pakyz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0225","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2010.11.014_bib0230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910004759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910004759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T18:20:56Z","timestamp":1636914056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910004759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":46,"alternative-id":["S0924857910004759"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.11.014","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}